368 Chapter 12 149. Brandsema PS, Dijkstra F, Euser SM, Van Gageldonk-Lafeber AB, De Lange MMA, Meijer A, et al. Rijksinstituut voor Volksgezondheid en Milieu (RIVM). Jaarrapportage Surveillance Respiratoire Infectieziekten 2012. 2013 [Available from: https://www.rivm.nl/bibliotheek/rapporten/150207001.pdf. 150. Thomas Y, Kaiser L. Influenza virus surveillance in Switzerland Season 2012–2013 2013 [Available from: https://www.hug-ge.ch/sites/interhug/files/structures/ laboratoire_de_virologie/documents/flu2013.pdf. 151. Mosnier A, Caini S, Daviaud I, Bensoussan JL, Stoll-Keller F, Bui TT, et al. Ten influenza seasons in France: distribution and timing of influenza A and B circulation, 2003-2013. BMC Infect Dis. 2015;15:357. 152. Mancinelli L, Onori M, Concato C, Sorge R, Chiavelli S, Coltella L, et al. Clinical features of children hospitalized with influenza A and B infections during the 20122013 influenza season in Italy. BMC Infect Dis. 2016;16:6. 153. Pariani E, Amendola A, Piatti A, Anselmi G, Ranghiero A, Bubba L, et al. Ten years (2004-2014) of influenza surveillance in Northern Italy. Hum Vaccin Immunother. 2015;11(1):198-205. 154. van de Sandt CE, Bodewes R, Rimmelzwaan GF, de Vries RD. Influenza B viruses: not to be discounted. Future Microbiol. 2015;10(9):1447-65. 155. Olson DR, Heffernan RT, Paladini M, Konty K, Weiss D, Mostashari F. Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City. PLoS Med. 2007;4(8):e247. 156. Walter D, Bohmer MM, Heiden M, Reiter S, Krause G, Wichmann O. Monitoring pandemic influenza A(H1N1) vaccination coverage in Germany 2009/10 - results from thirteen consecutive cross-sectional surveys. Vaccine. 2011;29(23):4008-12. 157. Ollila HM, Sharon E, Lin L, Sinnott-Armstrong N, Ambati A, Yogeshwar SM, et al. Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy. Nat Commun. 2023;14(1):2709. 158. Ding Q, Li J, Xiao F, Zhang C, Dong X, Han F. Anti-streptococcal antibodies in Chinese patients with type -1 narcolepsy. Sleep Med. 2020;72:37-40. 159. Zhang Z, Gool JK, Fronczek R, Dauvilliers Y, Bassetti CLA, Mayer G, et al. New 2013 incidence peak in childhood narcolepsy: more than vaccination? Sleep. 2021;44(2). 160. Caini S, Kusznierz G, Garate VV, Wangchuk S, Thapa B, de Paula Junior FJ, et al. The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century. PLoS One. 2019;14(9):e0222381. 161. Zaraket H, Hurt AC, Clinch B, Barr I, Lee N. Burden of influenza B virus infection and considerations for clinical management. Antiviral Res. 2021;185:104970. 162. Wang X, Xiao F, Wang Y, Deng X, Chen Z, Dong X, et al. Changed epidemiology of narcolepsy before, during, and after the 2009 H1N1 pandemic: a nationwide narcolepsy surveillance network study in mainland China, 1990-2017. Sleep. 2023;46(3). 163. Gool JK, Zhang Z, Fronczek R, Amesz P, Khatami R, Lammers GJ. Potential immunological triggers for narcolepsy and idiopathic hypersomnia: Real-world insights on infections and influenza vaccinations. Sleep Med. 2024;116:105-14. 164. Evangelista E, Lopez R, Barateau L, Chenini S, Bosco A, Jaussent I, Dauvilliers Y. Alternative diagnostic criteria for idiopathic hypersomnia: A 32-hour protocol. Ann Neurol. 2018;83(2):235-47. 165. Ziegler T, Mamahit A, Cox NJ. 65 years of influenza surveillance by a World Health Organization-coordinated global network. Influenza Other Respir Viruses. 2018;12(5):558-65.
RkJQdWJsaXNoZXIy MjY0ODMw